Rami Abdou, MD
Otolaryngology · Los Angeles, CANPI 1700143013
Payments from drug & device makers
Across 63 payments — averaging $87.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Stryker$2K
- Acclarent, Inc$316
- Optinose US, Inc.$257
- Boston Scientific$65
- Inspire Medical Systems, Inc.$31
- plus $132 from 6 others
What the payments were for
- Travel & lodging$1,91935%
- Food & beverage$3,58465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 12 | $2,691 |
| Stryker | 28 | $2,012 |
| Acclarent, Inc | 4 | $316 |
| Optinose US, Inc. | 7 | $257 |
| Boston Scientific | 3 | $65 |
| Inspire Medical Systems, Inc. | 2 | $31 |
| Xoran Technologies LLC | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Organon | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Aerin Medical Inc. | 1 | $18 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$2,289
- SINUVA$2,289
- ENTELLUS - XPRESS ENT DILATION SYSTEM$553
- CLARIFIX CRYOTHERAPY DEVICE$351
- ENTELLUS - FOCESS SINUSCOPES$132
- Xhance$126
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$125
- TruDi$120
How this compares
$5,504 in reported general payments places this provider in the 85th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 14 | $534 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 28 | $478 |
| Mupirocin | 51 | $333 |
| Ipratropium Bromide | 15 | $309 |
| Fluticasone Propionate | 31 | $234 |
| Omeprazole | 26 | $206 |
| Chlorhexidine Gluconate | 14 | $65 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Los Angeles
- Keith BlackwellLos Angeles$349K
- Martin HoppLos Angeles$321K
- Arthur WuLos Angeles$279K
- Dennis TangLos Angeles$261K
- Jeffrey SuhLos Angeles$228K
- Kevin ChoiLos Angeles$190K
- Elisabeth FerenceLos Angeles$124K
- Gene LiuLos Angeles$84K
- Robert KangLos Angeles$57K
- Richard MichelinLos Angeles$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.